Buy above $9If price drops back below $9, I'm going to be having a word with the charting gods. The technical setup here is very textbook.
White boxes on the chart may be fractals.
(Essentially, waves of momentum that ripple through like little mirror signatures after the initial wave.)
Tilray has a crazy awesome bullish setup over the next month or two, but oddly other markets I am seeing bearish signs. The only explanation I can think of is maybe Tilray is partly seen as a recessionary play due to their alcohol business and capital is switching sectors. One positive sign for Tilray is even though it is listed in the Nasdaq, even while the Nasdaq was red today (01/02/26), Tilray was UP +7%. Unexpected bullish divergence.
The other option is that this is all liquidity based and it's just the fact that rescheduling cannabis should lead to greater liquidity in the sector.
Who knows.
But!
IF the gods aren't completely screwing with us, Tilray should revisit $15 in the next few months. If Trump comes out and says, "Actually, I lied, and weed is bad." THEN the rally could end and we reverse the whole thing.
I love this stock long-term no matter what.
I think when the U.S. Treasury goes tits up, obviously everything will enter crisis, but they'll love cannabis once we peasants really get pissed and start banging on the doors. They'll legalize weed while we enter a lost decade and reshuffle the monetary system.
One day, cannabis will be a commodity again, like wheat, cotton, etc., but that's just my opinion and a bit of a historical cycle thing.
Weedstocks
Sundial Vs Wyckoff Accumulation Schematic, Ready For Lift Off!SNDL has clearly been under accumulation for a while and so I pulled up the Wyckoff schematic #1 for accumulation. It sure looks fitting to me. I have been in for a while but I will be adding more here.
SNDL Inc. is emerging as one of the leading vertically integrated cannabis companies in North America, showing strong signs of operational and financial turnaround in 2025. In Q2 2025, SNDL reported net revenue of $244.8 million, marking a solid 7.3% year-over-year increase, driven largely by a remarkable 17.4% growth in its cannabis business segment and a resurgence in its liquor retail division. Impressively, this quarter marked the first time SNDL achieved positive operating income and net earnings, highlighting the effectiveness of its strategic initiatives.
The company has demonstrated financial discipline by maintaining a robust cash reserve of over $208 million and exiting the period completely debt-free, positioning it well for future growth. SNDL is advancing its growth strategy through significant investments, including a $32.2 million acquisition of 32 new cannabis retail locations from 1CM Inc. and launching the Rise loyalty program to deepen customer engagement. Moreover, SNDL is expanding internationally with increased exports to the UK and European markets, diversifying its revenue streams beyond North America.
This combination of revenue growth, profitability milestone, strategic expansion, and financial strength solidifies SNDL's potential as a top cannabis stock in 2025. With a diversified portfolio of cannabis and liquor retail brands, SNDL is well positioned to capitalize on the growing legal cannabis market and maintain momentum in both domestic and international arenas.
This bullish case for SNDL emphasizes its operational execution, market expansion, and newfound profitability as drivers of long-term shareholder value. Not financial advice, DYOR.
Greenlane, perhaps a matter of time. But sooner than later...GNLN has been slammed yet we have decent fundamentals. The cannabis sector is ripe for pickings, one like this could be a gem yet to launch after being hammered down.
Here’s a positive, logically structured post you could use for GNLN (Greenlane Holdings):
Greenlane Holdings (GNLN) is one of those under-the-radar plays that the market has largely discounted, yet logic points to upside potential. The stock has been heavily beaten down, primarily due to sector pressure and dilution tied to past pivots, but the current setup leaves room for appreciation if you look beyond the negative headlines.
Market Position: GNLN is still a leading distributor of premium cannabis accessories, packaging, and vape technology. While many cannabis-touching companies face regulatory hurdles, GNLN operates on the ancillary side, meaning it doesn’t have the same legal exposure or cultivation costs. That’s a lower-risk niche with steady demand.
Industry Tailwinds: With increasing legalization momentum both at the state and federal level, accessory and packaging demand is a direct beneficiary. Every time new states open up, someone needs to sell the hardware, packaging, and storage solutions that GNLN specializes in. They’re positioned to ride the wave without production risks.
Operational Improvements: Management has been cutting costs, restructuring operations, and focusing on leaner growth. Smart capital preservation now means more runway to capture future sector upside.
Valuation Logic: After reverse splits and dilution, the float is still relatively low compared to many cannabis peers. This leaves room for big percentage swings when volume comes in. If you look at relative valuations in the cannabis accessory sector, GNLN trades at a steep discount.
Catalysts: Any progress in U.S. federal reform, SAFE banking, or industry expansion news could reignite interest in names like GNLN. Given how beaten down it is, even modest improvements in sentiment could translate to outsized percentage gains. Not financial advice, DYOR
Canopy Growth: Further UpwardThe WEED stock has already realized considerable increases during the current green wave B, which we credit with even more upward potential. However, we primarily expect the top of this movement to be marked below the resistance at C$3.11, and subsequently, the price should move deeper into our magenta Target Zone between C$2.96 and C$0.90 to complete the larger wave ii in orange. The following wave iii should then lead WEED out of the magenta zone and peak above the mentioned C$3.11 resistance. If the stock already rises above this mark during the current movement, we will have to assume that wave alt. ii in orange has already concluded (probability: 37%).
WM Technology | MAPS | Long at $1.00WM Technology NASDAQ:MAPS provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. After it's de-SPAC in 2020, it soared to $29.50 and now can be found for around $1.00. It's been consolidating at these lows for almost two years, and it may be gaining algorithmic traction for a move soon based on my selected simple moving average (SMA). Often (but not always), when this SMA gets close to the price, there is a pop to the historical SMA. Currently, it is in a personal buy zone at $1.00.
Target #1 = $1.50
Target #2 = $2.00
Weed stocks over sold from tax loss harvesting?Ive traded gtbif green thumb successful before and think this might be the time to trade again. Gtbif is one of the biggest holdings inside this Msos etf.
I like the etf MSOS, the shares of GTBIF, and any of the other profitable Cannabis stocks.
Looking for mean reversion, even 2x upside potentially.
Long 3 strike calls on MSOS.
if trade in options works, I may roll back into the etf and keep for free from gains.
Planet 13 Holdings | PLNH | Long at $0.39The marijuana sector has taken a beating over the last few years, yet certain companies may provide value and dominate the space in the future. Enter Planet 13 Holdings $OTC:PLNH. This OTC play warrants extreme caution, though. It's either going to zero or could produce massive returns. My personal logic is not to bet the farm with any OTC play, but maybe an old goat ... and potentially buy the farm in the future.
From a technical analysis perspective, my selected historical simple moving average (SMA) line is approaching the current price of $0.39. Frequently, as this SMA line and price get closer to each other, there is a pop in the price.
Fundamentally, financial growth is anticipated. Financial highlights from the Q3 2024 report state that the company's revenue was $32.2 million as compared to $24.8 million, an increase of 29.7%. The increase in sales was driven by the addition of Florida as well as strong sales in Illinois. Gross profit was $16.7 million or 51.9% as compared to $11.1 million or 44.7%. Free cash flow: $108,807 million. Operationally, OTC:PLNH looks pretty good on paper.
Marijuana legalization in the US is only going to expand. It's inevitable given the changing sentiment around the topic. If OTC:PLNH can do well in this space and is able to continue to grow, this ticker could get very interest. Thus, at $0.39, OTC:PLNH is in a personal buy zone.
Target #1: $0.55
Target #2: $0.75
Target #3: $1.00
Target #4: $5.75 (very long-term outlook if legalization spreads...)
GrowGeneration | GRWG | Long at $1.90GrowGeneration NASDAQ:GRWG is approaching one of my favorite technical analysis setups as it gets closer to my selected historical simple moving average (SMA: the white and teal lines). Often, but not always (i.e. public offering news...), the price will jump to the selected historical SMA after a long period of consolidation - which has been occurring for some time. Additionally, the President, CEO, and Director of NASDAQ:GRWG have been buying shares recently near $2 which is a bullish indicator. There are currently only 54.8 million floating shares and an 8%+ short interest, so this could get interesting if the election cycle whips up new interest/chatter about national decriminalization of marijuana. As a result, GrowGeneration is in a personal buy zone at $1.90.
Target #1 = $2.20
Target #2 = $2.50
Target #3 = $3.00
Target #4 = $3.50
Tilray - Its timeTilray has completed a type 2 bullish shark and caught followthrough price action on Friday.
Long to the three targets. If you are seeing this late then I'd wait on a down day to enter, if it never comes then you've missed the entry and another opportunity will arise.
We are also long on SNDL with a similar but weaker setup
send $acb back to $1002024 has been very busy for NASDAQ:ACB
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
when looking at the chart we can see obvious price discovery to the downside, and the last year of lows have come with heavy market selling. however on the plus side the buy pressure has been positive in the background suggesting someone is happy to scoop up the stock down here.
its only a matter of time before NASDAQ:ACB picks up again given the company are now debt free :-)
"Canopy Growth Corporation Faces Critical Support Test"Canopy Growth Corporation: Navigating Market Challenges and Strategic Goals
Canopy Growth Corporation, a prominent player in the cannabis industry, has been a focal point for investors seeking exposure to the rapidly expanding market for legal marijuana products. As one of the largest cannabis producers globally, Canopy Growth has garnered attention for its ambitious goals and strategic initiatives aimed at capitalizing on the burgeoning demand for cannabis-related products.
Founded in 2013, Canopy Growth has quickly risen to prominence, establishing itself as a leader in the cannabis industry through a combination of strategic acquisitions, innovative product development, and global expansion efforts. The company's primary focus is on cultivating, producing, and distributing a diverse range of cannabis products, including dried flower, oils, edibles, and beverages.
In recent years, Canopy Growth has achieved several notable milestones, reflecting its commitment to growth and innovation. These achievements include expanding its production capacity, securing distribution agreements with leading retailers, and launching new product lines to meet evolving consumer preferences.
However, despite its successes, Canopy Growth has faced challenges in navigating the volatile cannabis market, particularly in the wake of a prolonged distribution bear market that has persisted for the past five years. The company's stock price has experienced significant fluctuations, reflecting the uncertainty surrounding regulatory environments, shifting consumer trends, and competitive pressures within the industry.
Recently, Canopy Growth's stock price experienced a sharp retracement, testing critical support levels around $18 per share. With the stock now poised to retest its previous lows at $4 per share, investors are closely monitoring the situation for signs of a potential breakout or breakdown.
The recent spike in volume accompanying the bounce from support suggests heightened volatility and the potential for significant price movements in the near term. Bears may attempt to crack support levels, with the possibility of a further downward spiral if volume flows through aggressively enough. In such a scenario, the stock could potentially retest long-term downward support levels around $2 per share.
On the other hand, if Canopy Growth manages to break out of its current pennant pattern, investors may view this as an opportunity to enter a position targeting the top of long-term resistance levels. A successful breakout could pave the way for renewed upward momentum, offering potential upside for savvy traders.
In conclusion, Canopy Growth Corporation continues to navigate challenges in the cannabis market while pursuing strategic goals aimed at driving long-term growth and profitability. As the company grapples with support levels and potential breakout opportunities, investors should remain vigilant and adaptable, prepared to capitalize on emerging trends and developments in this dynamic industry.
TLRY's Green Revolution Cannabis Stocks on the NYSEAs of the most recent data, the S&P 500, which represents the performance of 500 of the largest companies listed on stock exchanges in the United States, is trading at an impressive level. The index has been on a bullish trend, consistently reaching new all-time highs in recent months. This upward trajectory can be attributed to a combination of factors, including strong corporate earnings, optimism surrounding economic recovery, and accommodative monetary policies from central banks. Investors' appetite for risk remains robust, and as long as these favorable conditions persist, the S&P 500's bullish trend is likely to continue, attracting both institutional and retail investors.
MSOS wanna get HIGH?erf you find this information inspiring/helpful, please consider a boost and follow! Any questions or comments, please leave a comment! Also, check out the links in my signature to get to know me better!
MSOS News pump, so a short based off of past trends could be warrented, but watching for a nice correction and some reactions off of these levels starting at 6.44 and 5.56.
SHORT Leafly - lost over 99% since the IPO.Since the IPO, Leafly has lost over 99% of its value.
Leafly's management team throws shares at retail investors on a monthly basis and feeds the short positions of hedge funds.
As long as Leafly continues to get beat up by hedge funds, prices will continue to fall.
There is steadily more selling than buying. The demand is very low.
In the long term, the stock could be interesting.
GRWG buy the dip!First off for summary:
Grow Generation is a leading retailer of hydroponic and organic gardening products in the United States. The company was founded in 2014 and is headquartered in Denver, Colorado. Grow Generation provides a wide range of products and services for indoor and outdoor gardening, including hydroponic and organic growing equipment, nutrients, and supplies. The company operates more than 30 retail locations in 13 states and is committed to providing high-quality products, expert advice, and excellent customer service to its customers. With a growing customer base of professional cultivators and home gardeners, Grow Generation is well positioned for continued growth in the hydroponic and organic gardening industries.
TA: It is very clear we are under the 5year trend line.
In 2018/2019 when GRWG was at these prices the revenue was a 4th of what it is now so even with the marco economic outlook uncertain, I think this is a great buying opportunity.
These guys are growing at a healthy rate and there is still a large untapped market in the midwest that they are positioned well to capture. I've been watching more and more folks convert from alcohol to delta 8 products and it's only a matter of time before the feds decriminalize delta 9 sales.
I think we will break above $10 by summer.
If we test new lows I'd reconsider.
Aurora: Sleeping Beauty 👸It's time to activate our wake-up call to get Aurora back into motion, since we expect the course to rise up North, even though it is still creeping sideways momentarily. In our alternative scenario, there is a slight probability of 33% that the course could drop below the $1.14 support line instead. In this case, it would continue to move South until it reaches the low of the grey wave alt. II. Primarily, the stock should make the climb and fulfill the blue wave (iii) before dropping into a correction of the blue wave (iv). Once completed, the course should have gained momentum to be able to exceed the resistance line at $2.49 and wander further North in order to complete the pink wave .
Jazz Pharmaceuticals: High Life 🍁It must be 420 somewhere, since the Jazz Pharmaceuticals stock is paving its way higher and higher to ultimately reach the orange target zone. Once the blue wave (b) is completed, the stock should drop all the way below the $125.36 support line and continue the correction until the end of the green wave within the yellow trading area. Once the course has hit the corrective low, it can turn back up and start a sturdy upwards trend.
Canopy Growth: Ball Drop 🪩Just like the Ball in Times Square every New Year's Eve, the Canopy Growth stock is currently dropping it low. We expect the course to dig deeper into the blue trading area between C$3.49 and C$0.70 until it finishes the grey wave II. After completion, we're expecting the course to rise further North in the longterm. In our alternative scenario, the Canopy Growth stock course might exceed the C$5.55-mark already now, without pushing for further lows below the support line.






















